Organizations

Below are resources where you can find additional information and resources for Chronic Granulomatous Disease (CGD).

Immune Deficiency Foundation (IDF)

www.primaryimmune.org | 800-296-4433

The Immune Deficiency Foundation (IDF) is the national patient organization dedicated to improving the diagnosis, treatment, and quality of life of persons with primary immunodeficiency diseases, such as CGD, through advocacy, education, and research. IDF provides accurate and timely information and resources to patients and healthcare professionals.

American Academy of Allergy Asthma & Immunology

www.aaaai.org | 313-371-8600 | Physician Referral Service 800-822-2762

The American Academy of Allergy, Asthma, and Immunology (AAAAI) is a professional organization for physicians who treat patients with allergies, asthma and immunologic disorders. The organization provides a worldwide referral system for physicians in various geographical regions. Click here for AAAAI’s overview of CGD.

Chronic Granulomatous Disease Association

www.cgdassociation.org

The Chronic Granulomatous Disease Association (CGDA) is a nonprofit organization dedicated to helping patients with CGD and their caregivers, and advancing research toward a cure.

CGD Society

www.cgdsociety.org

The CGD Society is an organization based in the United Kingdom that offers support and information to patients and families affected by CGD.

Clinical Immunology Society

www.clinimmsoc.org | 414-224-8095

The mission of the Clinical Immunology Society (CIS) is to facilitate education, translational research and novel approaches to therapy in clinical immunology to promote excellence in the care of patients with immunologic/inflammatory disorders.

Horizon Pharma

www.horizonpharma.com/chronic-granulomatous-disease/

Horizon Pharma is a specialty biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. Horizon manufactures ACTIMMUNE, a bioengineered form of interferon gamma-1b, a protein that acts as a biologic response modifier through stimulation of the human immune system.